News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
May, 2025
May 2025
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Giuseppe Banna: Enjoyed being part of the EAU 2025 Symposium
Giuseppe Banna/LinkedIn
Mar 24, 2025, 09:15

Giuseppe Banna: Enjoyed being part of the EAU 2025 Symposium

Giuseppe Banna, Consultant Medical Oncologist at Portsmouth Hospitals University NHS Trust, shared a post on LinkedIn:

“I truly enjoyed being part of this insightful symposium with Verane Achard, Teresa Lopez, and Alberto Briganti at EAU25, discussing relugolix, an LHRH antagonist with lower cardiovascular risk and rapid, profound castration and PSA decline.

It makes a valuable option in metastatic hormone-sensitive prostate cancer (mHSPC), particularly in the context of treatment de-escalation strategies. – Giuseppe Banna

Great discussions and perspectives – looking forward to continuing the conversation!”

Giuseppe Banna

Alberto Briganti cancer cardiovascular risk EAU25 Giuseppe Banna Metastatic Hormone-sensitive Prostate Cancer OncoDaily Oncology prostate cancer Teresa Lopez Verane Achard
Special Coverage
Blog
May 9, 2025, 10:37
Yuji Uehara: Thrilled to Receive a Travel Grant for ESMO TAT Asia25
Blog
May 9, 2025, 10:32
Julie Torode Believes That Collaboration Is Key to Ending Global Ovarian Cancer Inequities - World Ovarian Cancer Coalition
Blog
May 9, 2025, 10:29
Cathy Eng: Polyps Removed, so Back Again in 3 years
Blog
May 9, 2025, 10:15
Sarah Sammons Comments on TDXd Use in Early HER2+ Breast Cancer
Blog
May 9, 2025, 10:04
Aakash Desai: AI in Predicting EGFR Mutations from Whole Slide Images in Lung Cancer
Blog
May 9, 2025, 09:39
Yakup Ergün: One of the Key Upcoming Presentations at ESMO Breast 2025
Blog
May 9, 2025, 09:37
Erika Hamilton: PROTAC Data at ASCO25 in the MBC Oral Session
Blog
May 9, 2025, 09:29
ESO - M2ICOS Project Launches Fellowship Program to Support Oncology Training and Mobility in the EU
Science
May 9, 2025, 09:22
Myeloma Paper of the Day, May 9th, suggested by Robert Orlowski
Drugs
May 9, 2025, 09:15
Penpulimab: Uses in Cancer, Side Effects, Dosage, Expectations, and More
Drugs
May 9, 2025, 08:47
Jonathan Pachter: FDA Grants Accelerated Approval for 1st Targeted Therapy in KRAS-Mutant LGSOC
Blog
May 9, 2025, 08:15
Parminder Singh: Grand Rounds at Mayo Clinic